1. Home
  2. PFX vs GNTA Comparison

PFX vs GNTA Comparison

Compare PFX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFX

PhenixFIN Corporation

HOLD

Current Price

$46.38

Market Cap

83.9M

Sector

Finance

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.30

Market Cap

69.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFX
GNTA
Founded
2010
2014
Country
United States
Italy
Employees
7
9
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.9M
69.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PFX
GNTA
Price
$46.38
$1.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.6K
57.4K
Earning Date
05-08-2026
03-24-2026
Dividend Yield
3.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.30
$0.55
52 Week High
$53.00
$10.00

Technical Indicators

Market Signals
Indicator
PFX
GNTA
Relative Strength Index (RSI) 58.56 41.49
Support Level $40.93 $1.30
Resistance Level $51.45 $1.70
Average True Range (ATR) 2.78 0.12
MACD 0.27 -0.03
Stochastic Oscillator 64.85 20.00

Price Performance

Historical Comparison
PFX
GNTA

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: